Adaptimmune Therapeutics plc (ADAP) exploded mid-Jan, pulled back, I put a swing on it, it popped but couldn’t break out, consolidated another month on low volume, and on Thursday, it was an engulfing reversal day, popping 26 cents, or 7.5%, to 3.72, just 5 cents off the session high at 3.77, but still on very low volume at 398,522 shares traded. It may be the beginning of something. We’ll see if it has a follow-through. Targets are 4 3/4 and 6.

BioXcel Therapeutics, Inc. (BTAI) has a really nice-looking pattern. I may be putting a swing on it. It’s four waves up. The pop on Thursday took it up another 2.21, or 7.38%, to 32.17, with a session high of 35, on 1 million shares traded. If it ramps five waves up, it will be 60, or better.

GenMark Diagnostics, Inc. (GNMK) had a very explosive day on Thursday, jumping 1.06, or 23%, to 5.63, after running up to 5.97 earlier in the day, on 10 million shares traded. That’s the biggest volume ever for this stock. Now that it’s four days up with a gap, as well, I think the possibility that this stock will make a more substantial move is pretty good now that it’s taken out the declining topsline with a thrust. If there’s follow-through, I expect it to run up to 6 1/2-7, and then maybe 8.

Inovio Pharmaceuticals, Inc. (INO) exploded again on Thursday, jumping another 1.78, or 22%, to 10.10, before pulling back and closing up 9.80, on 110.4 million shares traded. Wednesday’s volume was 140 million shares traded. In just three days, this stock has traded a third of a billion shares. It might be a little short-term extended. There’s a little resistance at 11 1/2, and then 13 1/2-14 if it does try to extend.

Sangamo Therapeutics, Inc. (SGMO) popped, broke out, I put a swing on it, and it backed off. Thursday it reversed from 8 to 8.53, gaining 40 cents, or 5%, in addition to another 32 cents, or 3.75%, to 8.86, in after-hours, on 5.2 million shares traded. If it gets above 9.20, I’m looking for 10 1/2 and 12 going forward.

Vipshop Holdings Limited (VIPS) had a significant breakaway gap above two moving averages and double top at the top of the channel, closing up 3.54, or 27%, to 16.66, after reaching session and multi-week high at 17.06, on 37 million shares traded. That’s a huge move. I think it’s a breakout move and not a top. There’s some resistance here so there may be some backing and filling. I’m looking at 19 for the next target.

Stocks on the long side included Adaptimmune Therapeutics plc (ADAP), Digital Turbine, Inc. (APPS), Atomera Incorporated (ATOM), BioXcel Therapeutics, Inc. (BTAI), Eldorado Gold Corporation (EGO), Fulgent Genetics, Inc. (FLGT), GenMark Diagnostics, Inc. (GNMK), Inovio Pharmaceuticals, Inc. (INO), KORU Medical Systems (KRMD), Moderna, Inc. (MRNA), NantKwest, Inc. (NK), Neoleukin Therapeutics, Inc. (NLTX), Novavax, Inc. (NVAX), Omeros Corporation (OMER), Sangamo Therapeutics, Inc. (SGMO), Surface Oncology, Inc. (SURF), Teladoc Health, Inc. (TDOC), Tandem Diabetes Care, Inc. (TNDM), Trillium Therapeutics Inc. (TRIL), VelocityShares Daily 2x VIX Short-Term ETN (TVIX), ProShares Ultra VIX Short-Term Futures ETF (UVXY), Vipshop Holdings Limited (VIPS), Slack Technologies, Inc. (WORK), WW International, Inc. (WW), World Wrestling Entertainment, Inc. (WWE), and Zynex, Inc. (ZYXI).